Thymoquinone, a Promising Therapeutic Candidate in Pancreatic Cancer

The poor prognosis and high mortality of pancreatic cancer has prompted clinicians and researchers from around the world to understand the molecular pathways of pancreatic cancer and develop new treatments. Previous studies have shown that thymoquinone, the major active component in black seed, could be a “novel therapy” against pancreatic cancer. Here, we discuss in vivo and in vitro experiments which provided us with a new understanding of the therapeutic effects thymoquinone has on pancreatic cancer cells. These experiments used pancreatic ductal adenocarcinoma cell lines to conduct experiments, which accounts for about 90% of all pancreatic cancer cases.